| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $63.5M | +21.9% |
| Cost of Revenue | $15.1M | +35.1% |
| Gross Profit | $48.3M | +18.2% |
| R&D Expense | $19.1M | +4.0% |
| SG&A Expense | $12.6M | +0.3% |
| Operating Income | -$3.0M | +72.4% |
| Pre-tax Income | -$3.4M | +76.5% |
| Income Tax | -$857K | +87.2% |
| Net Income | -$2.1M | +76.2% |
| EPS (Basic) | -$0.00 | +66.7% |
| EPS (Diluted) | -$0.00 | +66.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.6M | -21.4% |
| Short-term Investments | $5.0M | — |
| Accounts Receivable | $3.7M | +42.3% |
| Current Assets | $43.9M | -4.9% |
| Total Assets | $69.5M | -0.3% |
| Current Liabilities | $23.6M | +10.0% |
| Total Liabilities | $24.7M | +14.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.3M | +141.0% |
| Capital Expenditures | $251K | -72.9% |
| Investing Cash Flow | -$8.9M | -138.7% |
| Financing Cash Flow | $794K | +108.9% |
| Free Cash Flow | $1.0M | +125.5% |
| Stockholders' Equity |
| $59.3M |
| -5.6% |